SCHEMBL30906357

CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.57

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	NPY1R	P25929	1/20	0.57

▸	NPY2R	P49146	1/20	0.57

▸	NPY4R	P50391	1/20	0.57

▸	NPY5R	Q15761	1/20	0.57

▸	GLP1R	P43220	17/20	0.56

▸	GIPR	P48546	6/20	0.53

▸	ECE1	P42892	1/20	0.53

▸	MUS81	Q96NY9	1/20	0.53

▸	GALR2	O43603	1/20	0.52

▸	GALR1	P47211	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906418	0.93	NPY1R (0.57)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906332	0.92	GLP1R (0.55)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906348	0.92	NPY1R (0.51)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906505	0.91	NPY1R (0.58)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906407	0.90	GLP1R (0.58)	GLP1RGIPRGALR2GALR1
SCHEMBL30906366	0.89	NPY1R (0.53)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906519	0.89	NPY1R (0.54)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906406	0.89	NPY1R (0.56)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906342	0.88	CAPN1 (0.53)	GLP1RGIPR
SCHEMBL30906530	0.88	CALCA (0.54)	NPY1RNPY2RNPY4RNPY5RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed